American Regent Logo Corporate Seperator

Investigator Initiated Study
Investigator Initiated Study Information and Submission

American Regent, Inc. is committed to supporting Investigator Initiated Studies (IIS) to address medically and scientifically sound research for the management of iron deficiency anemia (IDA), related to Injectafer® (ferric carboxymaltose injection).

Please review the following guidance and the Investigator Initiated Studies Guidance Document below to submit an IIS proposal:


Click here to review Investigator Initiated Studies Guidance



Click here to download the Investigator Initiated Studies Proposal Synopsis Form



Please submit the completed Proposal Synopsis Form and supportive documentation to IST@americanregent.com Once American Regent, Inc. receives the completed proposal, it will be reviewed by our IIS committee in accordance with our company policy. The investigator will then be contacted once the committee has completed its review.






© 2018, American Regent, Inc., A Luitpold Pharmaceuticals, Inc. Company PP-CA-US-0001 (v7.0)     9/2018